Low-dose oxybutynin for the treatment of urge incontinence: good efficacy and few side effects.

Author: BemelmansB L, DebruyneF M, KiemeneyL A

Paper Details 
Original Abstract of the Article :
Oxybutynin is an efficacious pharmacotherapeutic agent for the treatment of urge incontinence. However, many patients discontinue therapy because of the considerable side effects. This study aims at assessing the efficacy of a low-dose oxybutynin (2.5 mg three times daily) in relation to the concomi...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000020222

データ提供:米国国立医学図書館(NLM)

Low-Dose Oxybutynin for Urge Incontinence: Efficacy and Side Effects

Urge incontinence, a common and often embarrassing condition, is like a desert traveler facing unexpected sandstorms. This research investigates the efficacy and side effects of low-dose oxybutynin, a medication commonly used to treat urge incontinence. The researchers assessed the effectiveness of a low-dose oxybutynin regimen (2.5 mg three times daily) in a group of patients with urge incontinence, finding that it was effective in reducing urinary urgency and frequency while producing fewer side effects than higher doses. This research suggests that low-dose oxybutynin could be a more tolerable and effective treatment option for individuals with urge incontinence.

A More Tolerable Approach to Urge Incontinence

The study suggests that low-dose oxybutynin can be an effective treatment for urge incontinence with fewer side effects than higher doses. This could potentially improve patient adherence to treatment and lead to better long-term outcomes for individuals with urge incontinence.

Navigating the Desert of Urinary Incontinence

This research is like a camel caravan exploring a desert of urinary incontinence, seeking more comfortable and effective ways to manage this challenging condition. The findings suggest that low-dose oxybutynin could offer a more tolerable and potentially more effective option for individuals seeking relief from urge incontinence.

Dr. Camel's Conclusion

This research is like a camel caravan discovering a more comfortable and effective path through the desert of urge incontinence. Low-dose oxybutynin offers a promising approach to managing this condition, potentially leading to improved quality of life for individuals seeking relief.

Date :
  1. Date Completed 2000-08-29
  2. Date Revised 2018-02-13
Further Info :

Pubmed ID

10828672

DOI: Digital Object Identifier

10.1159/000020222

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.